Antimicrobial Peptide Coating of Dental Implants: Biocompatibility Assessment of Recombinant Human Beta Defensin-2 for Human Cells

2013 ◽  
Vol 28 (4) ◽  
pp. 982-988 ◽  
Author(s):  
Patrick H. Warnke ◽  
Eske Voss ◽  
Paul A. J. Russo ◽  
Sebastien Stephens ◽  
Michael Kleine ◽  
...  
2016 ◽  
Vol 33 ◽  
pp. 64-77 ◽  
Author(s):  
Akhilesh Rai ◽  
Sandra Pinto ◽  
Marta B. Evangelista ◽  
Helena Gil ◽  
Silvar Kallip ◽  
...  

Author(s):  
X. Chen ◽  
X. C. Zhou ◽  
S. Liu ◽  
R. F. Wu ◽  
C. Aparicio ◽  
...  

Biomolecules ◽  
2021 ◽  
Vol 11 (3) ◽  
pp. 421
Author(s):  
Areetha R. D’Souza ◽  
Matthew R. Necelis ◽  
Alona Kulesha ◽  
Gregory A. Caputo ◽  
Olga V. Makhlynets

Antimicrobial peptides (AMPs) present a promising scaffold for the development of potent antimicrobial agents. Substitution of tryptophan by non-natural amino acid Azulenyl-Alanine (AzAla) would allow studying the mechanism of action of AMPs by using unique properties of this amino acid, such as ability to be excited separately from tryptophan in a multi-Trp AMPs and environmental insensitivity. In this work, we investigate the effect of Trp→AzAla substitution in antimicrobial peptide buCATHL4B (contains three Trp side chains). We found that antimicrobial and bactericidal activity of the original peptide was preserved, while cytocompatibility with human cells and proteolytic stability was improved. We envision that AzAla will find applications as a tool for studies of the mechanism of action of AMPs. In addition, incorporation of this non-natural amino acid into AMP sequences could enhance their application properties.


Biomaterials ◽  
2017 ◽  
Vol 116 ◽  
pp. 69-81 ◽  
Author(s):  
Kai Yu ◽  
Joey C.Y. Lo ◽  
Mei Yan ◽  
Xiaoqiang Yang ◽  
Donald E. Brooks ◽  
...  

2014 ◽  
Vol 30 ◽  
pp. e86-e87
Author(s):  
X. Chen ◽  
H. Hirt ◽  
Y. Li ◽  
S.-U. Gorr ◽  
C. Aparicio

FEBS Journal ◽  
2016 ◽  
Vol 283 (11) ◽  
pp. 2115-2131 ◽  
Author(s):  
Katia Pane ◽  
Valeria Sgambati ◽  
Anna Zanfardino ◽  
Giovanni Smaldone ◽  
Valeria Cafaro ◽  
...  

2020 ◽  
Vol 55 (4) ◽  
pp. 503-510 ◽  
Author(s):  
Dongdong Fang ◽  
Sivan Yuran ◽  
Meital Reches ◽  
Raisa Catunda ◽  
Liran Levin ◽  
...  

1990 ◽  
Vol 54 (11) ◽  
pp. 688-689 ◽  
Author(s):  
J Jacobson ◽  
B Maxson ◽  
K Mays ◽  
J Peebles ◽  
C Kowalski

2002 ◽  
Vol 72 (3) ◽  
pp. 147-153 ◽  
Author(s):  
Kei-Ichi Hirai ◽  
Jie-Hong Pan ◽  
Ying-Bo Shui ◽  
Eriko Simamura ◽  
Hiroki Shimada ◽  
...  

The possible protection of cultured human cells from acute dioxin injury by antioxidants was investigated. The most potent dioxin, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), caused vacuolization of the smooth endoplasmic reticulum and Golgi apparatus in cultured human conjunctival epithelial cells and cervical cancer cells. Subsequent nuclear damage included a deep irregular indentation resulting in cell death. A dosage of 30–40 ng/mL TCDD induced maximal intracellular production of H2O2 at 30 minutes and led to severe cell death (0–31% survival) at two hours. A dose of 1.7 mM alpha-tocopherol or 1 mM L-dehydroascorbic acid significantly protected human cells against acute TCDD injuries (78–97% survivals), but vitamin C did not provide this protection. These results indicate that accidental exposure to fatal doses of TCDD causes cytoplasmic free radical production within the smooth endoplasmic reticular systems, resulting in severe cytotoxicity, and that vitamin E and dehydroascorbic acid can protect against TCDD-induced cell damage.


Sign in / Sign up

Export Citation Format

Share Document